-
Amputations Side Effects: Invokana Only, Or Jardiance, Farxiga, And Other SGLT2 Inhibitors Diabetes Drugs, Too?
Increasing Degree Of Acknowledgement In Medical Literature That Toe, Foot, And Leg Amputations Are Drug-Class Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) We have been following developments in the medical realm…
-
Waiting To See Whether FDA Approves Zelnorm In 2018 After Zelnorm Was Withdrawn In 2007 For Safety Reasons
Earlier Zelnorm Recall Was Due To Potential Cardiovascular Safety Signal, With Suicidal Ideation And Behavior Being Another Issue (Posted by Tom Lamb at DrugInjuryWatch.com) On October 17, 2018 the FDA’s Gastrointestinal Drugs…
-
Amputations Are SGLT-2 Inhibitors Drug-Class Side Effects It Now Appears, According To New Medical Evidence
Earlier Invokana Lower Limb Amputation Reports Are Being Followed By Farxiga And Jardiance Amputation Cases Now (Posted by Tom Lamb at DrugInjuryWatch.com) There is new medical evidence which suggests the hypovolemic effect…
-
Newer Diabetes Drugs Side Effect: Fournier’s Gangrene, Serious Infection Of Genital Area
FDA Mandates Label Changes With New Warnings For Invokana, Farxiga, Jardiance, Other SGLT2 Inhibitors (Posted by Tom Lamb at DrugInjuryWatch.com) In late August 2018 the FDA warned doctors and patients that cases…
-
Invokana / Jardiance / Farxiga: Increased Risks Of Lower-Limb Amputations Compared To Another Class Of Diabetes Drugs
Today Only The Invokana Drug Label Includes Warnings About Amputations Of Legs, Feet, And Toes; Will There Be Label Changes For Farxiga And Jardiance? (Posted by Tom Lamb at DrugInjuryWatch.com) Another new…
-
Diabetes Drug Tradjenta Associated With Bullous Pemphigoid, A Chronic Blistering Skin Condition
Bullous Pemphigoid (BP) Is An Auto-Immune Skin Disease Which Can Be Fatal, Particularly In Patients Who Are Debilitated (Posted by Tom Lamb at DrugInjuryWatch.com) Three relatively new medical studies add weight to…
